Диссертация (1335905), страница 25
Текст из файла (страница 25)
– P. 846-56.35.Block G.A. CKD-mineral and bone disorder and risk of death andcardiovascular hospitalization in patients on hemodialysis / G.A. Block, R.D.Kilpatrick, K.A. Lowe, W. Wang, M.D. Danese // Clin J Am Soc Nephrol. 2013. – Vol.8, №12. – P. 2132-40.36.Block, G.A. Mineral metabolism, mortality, and morbidity in maintenancehemodialysis / G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G.Lowrie, G.M.
Chertow // J Am Soc Nephrol. – 2004. – Vol15, №8. – P. 220818.37.Block, G.A. Mortality effect of coronary calcification and phosphate binderchoice in incident hemodialysis patients / G.A. Block, P. Raggi, A. Bellasi, L.Kooienga, D.M. Spiegel // Kidney Int. – 2007. – Vol.71, №5. – P. 438-41.38.Bolasco, P. Failed Switching off in the MIBI-Parathyroid Scintigraphy in aDialyzed Patient with Secondary Hyperparathyroidism Responsive toCinacalcet Therapy / P. Bolasco, A.
Serra, M. Loi, A. Galfré, M. Piga // Int JEndocrinol. – 2010. –206801.14739.Bover, J. Pro: Cardiovascular calcifications are clinically relevant/ J. Bover, P.Evenepoel, P. Ureña-Torres, M.G. Vervloet, V. Brandenburg, S. Mazzaferro, A.Covic, D. Goldsmith, Z.A. Massy, M. Cozzolino // Nephrol Dial Transplant. –2015. – Vol. 30, №3. – P.
345-51.40.Brandenburg, V.M. Calcific uraemic arteriolopathy: a rare disease with apotentially high impact on chronic kidney disease-mineral and bone disorder /V.M. Brandenburg, S. Sinha, P. Specht, M. Ketteler // Pediatr Nephrol. – 2014.– Vol.29, №12. – P. 2289-98.41.Brandenburg, V.M. Calcific uremic arteriolopathy: a call for action / V.M.Brandenburg, M. Cozzolino, S. Mazzaferro // Semin Nephrol.
– 2014. – Vol.34,№6. – P. 641-7.42.Brandenburg, V.M. Serological cardiovascular and mortality risk predictors indialysis patients receiving sevelamer: a prospective study / V.M. Brandenburg,G. Schlieper, N. Heussen, S. Holzmann, B. Busch, P. Evenepoel, R. Vanholder,B. Meijers, N.
Meert, W.J. Fassbender, J. Floege, W. Jahnen-Dechent, M.Ketteler // Nephrol Dial Transplant. – 2010. – Vol.25. – P. 2672–2679.43.Brown, E. Four-parameter model of the sigmoid relationship betweenparathyroid hormone release and extracellular calcium concentration in normaland abnormal parathyroid tissue / Brown E. // J Clin Endocrinol Metab. – 1983.– Vol.56. – H.572–581.44.Cannata-Andía J.B. Use of phosphate-binding agents is associated with a lowerrisk of mortality / J.B. Cannata-Andía, J.L.
Fernández-Martín, F. Locatelli, G.London, J.L. Gorriz, J. Floege, M. Ketteler, A. Ferreira, A. Covic, B.Rutkowski, D. Memmos, W.J. Bos, V. Teplan, J. Nagy, C. Tielemans, D.Verbeelen, D. Goldsmith, R. Kramar, P.Y. Martin, R.P. Wüthrich, D. Pavlovic,M. Benedik, J.E. Sánchez, P. Martínez-Camblor, M. Naves-Díaz, J.J.
Carrero,C. Zoccali // Kidney Int. – 2013. – Vol.84, №5. – P. 998-1008.45.Cardus, A. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cellproliferation through a VEGF-mediated pathway / A. Cardús, E. Parisi, C.148Gallego, M. Aldea, E.
Fernández, J.M. Valdivielso // Kidney Int. – 2006. –V.69. – P. 1377-1384.46.Cardus, A. Differential effects of vitamin D analogs on vascular calcification /A. Cardús, S. Panizo, E. Parisi, E. Fernández, J.M. Valdivielso / J Bone MinerRes. – 2007. - V.22. - P.860–866.47.Chertow, G.M.
Effect of cinacalcet on cardiovascular disease in patientsundergoing dialysis / G.M. Chertow, G.A. Block, R. Correa-Rotter, T.B.Drüeke, J. Floege, C.A. Herzog, G.M. London, K.W. Mahaffey, S.M. Moe,D.C. Wheeler, Y. Kubo, B. Dehmel, W.G. Goodman, P.S. Parfrey // N Engl JMed. – 2012.
– Vol.367, №26. – P. 2482-2494.48.Chertow, G.M. Supplement to: Effect of cinacalcet on cardiovascular disease inpatients undergoing dialysis / G.M. Chertow, G.A. Block, R. Correa-Rotter,T.B. Drüeke, J. Floege, C.A. Herzog, G.M. London, K.W. Mahaffey, S.M.Moe, D.C. Wheeler, Y.
Kubo, B. Dehmel, W.G. Goodman, P.S. Parfrey // NEngl J Med – 2012. – Vol.367, №26. – P. 2482-2494.49.Chertow, G.M. Treat to Goal Working Group. Sevelamer attenuates theprogression of coronary and aortic calcification in hemodialysis patients / G.M.Chertow, S.K. Burke, P. Raggi // Kidney Int. – 2002. – Vol.62 , №1. – P. 24552.50.Chin J. Activation of the calcium receptor by a calcimimetic compound haltsthe progression of secondary hyperparathyroidism in uremic rats / J. Chin, S.C.Miller, M. Wada, N. Nagano, E.F. Nemeth, J.
Fox // J Am Soc Nephrol. – 2000.– Vol.11, №5. –P.903-911.51.Cozzolino, M. VDRA therapy is associated with improved survival in dialysispatients with serum intact PTH ≤ 150 pg/mL: results of the Italian FAROSurvey / M. Cozzolino, D. Brancaccio, G. Cannella, P. Messa, L. Gesualdo, M.Marangella, C. LoDeserto, M.
Pozzato, G. Rombolà, A.M. Costanzo, U. diLuzio Paparatti, S. Mazzaferro // Nephrol Dial Transplant. – 2012. – Vol.27,№9. – P. 3588-94.14952.Culleton, B.F. Effect of frequent nocturnal hemodialysis vs conventionalhemodialysis on left ventricular mass and quality of life: a randomizedcontrolled trial / B.F. Culleton, M. Walsh, S.W. Klarenbach, G. Mortis, N.Scott-Douglas, R.R.
Quinn, M. Tonelli, S. Donnelly, M.G. Friedrich, A.Kumar, H. Mahallati, B.R. Hemmelgarn, B.J. Manns // JAMA. – 2007. –Vol.298, №11. – P. 1291-9.53.Danese, M.D. Consistent control of mineral and bone disorder in incidenthemodialysis patients / M.D. Danese, V. Belozeroff, K. Smirnakis, K.J.Rothman // Clin J Am Soc Nephrol. – 2008. – Vol.3, №5. – P. 1423-142954.Daniel, W.T. Prospective analysis of coronary calcium in patients on dialysisundergoing a near-total parathyroidectomy / W.T. Daniel, C. Weber, J.A.Bailey, P. Raggi, J. Sharma // Surgery.
– 2013. – Vol.154, №6. – P. 1315-21.55.Daugirdas, J.T. Effects of frequent hemodialysis on measures of CKD mineraland bone disorder / J.T. Daugirdas, G.M. Chertow, B. Larive, A. Pierratos, T.Greene, J.C. Ayus, C.A. Kendrick, S.H. James, B.W. Miller, G. Schulman, I.B.Salusky, A.S. Kliger // J Am Soc Nephrol. – 2012. – Vol.23, №4. – P. 727–738.56.de Barros Gueiros, J.E. Percutaneous ethanol (PEIT) and calcitrol (PCIT)injectiontherapyareineffectiveintreatingseveresecondaryhyperparathyroidism / J.E. de Barros Gueiros, M.C. Chammas, R.
Gerhard,C.F. da Silva Dias Boilesen, I.R. de Oliveira, R.M. Moysés, V. Jorgetti //Nephrol Dial Transplant. – 2004. – Vol.19, №3. – P. 657–663.57.de Francisco, A.L. Evaluation of calcium acetate/magnesium carbonate as aphosphate binder compared with sevelamer hydrochloride in haemodialysispatients: a controlled randomized study (CALMAG study) assessing efficacyand tolerability / A.L. de Francisco, M. Leidig, A.C.
Covic, M. Ketteler, E.Benedyk-Lorens, G.M. Mircescu, C. Scholz, P. Ponce, J. Passlick-Deetjen //Nephrol Dial Transplant. – 2010. – Vol.25. – P. 3707–3717.58.Delanaye, P. Cholecalciferol in haemodialysis patients: a randomized, doubleblind, proof-of-concept and safety study / P. Delanaye, L. Weekers, X. Warling,150M. Moonen, N. Smelten, L. Médart, J.M. Krzesinski, E.
Cavalier // Nephrol.Dial. Transplant. – 2013. – Vol.28, №7. – P. 1779-86.59.D'Haese, P.C. A multicenter study on the effects of lanthanum carbonate(Fosrenol) and calcium carbonate on renal bone disease in dialysis patients /P.C. D'Haese, G.B. Spasovski, A. Sikole, A. Hutchison, T.J. Freemont, S.Sulkova, C.
Swanepoel, S. Pejanovic, L. Djukanovic, A. Balducci, G. Coen, W.Sulowicz, A. Ferreira, A. Torres, S. Curic, M. Popovic, N. Dimkovic, M.E. DeBroe // Kidney Int Suppl. - 2003. – Vol.85. – P. 73-78.60.Douthat, W.G. Treatment of refractory secondary hyperparathyroidism withethanol injection: The importance of glandular volume / W.G. Douthat, S.E.Orozco, J. de Arteaga, P.U. Massari // Kidney International – 2003.
- Vol. 63(Suppl.85). - P.101-104.61.Douthat, W.G. Use of percutaneous ethanol injection therapy for recurrentsecondary hyperparathyroidism after subtotal parathyroidectomy / W.G.Douthat, G. Cardozo, G. Garay, S. Orozco, C. Chiurchiu, J. de la Fuente, J. deArteaga, P.U. Massari // Int J Nephrol. – 2011. - 246734.62.Drueke, T.B. Cell biology of parathyroid gland hyperplasia in chronic renalfailure/ T.B. Drueke // J Am Soc Nephrol. – 2000. – Vol.11. – P.
1141-1152.63.Drueke, T.B. Modulation and action of the calcium-sensing receptor / DruekeT.B. // Nephrol Dial Transplant. – 2004. – Vol.19 Suppl 5. – P. 20-26.64.Duranton, F. Vitamin D treatment and mortality in chronic kidney disease: asystematic review and meta-analysis / Duranton F., Rodriguez-Ortiz M.E.,Duny Y., Rodriguez M., Daurès J.P., Argilés A. // Am J Nephrol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
